Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Anne Dirkse"'
Autor:
Anne Dirkse, Anna Golebiewska, Thomas Buder, Petr V. Nazarov, Arnaud Muller, Suresh Poovathingal, Nicolaas H. C. Brons, Sonia Leite, Nicolas Sauvageot, Dzjemma Sarkisjan, Mathieu Seyfrid, Sabrina Fritah, Daniel Stieber, Alessandro Michelucci, Frank Hertel, Christel Herold-Mende, Francisco Azuaje, Alexander Skupin, Rolf Bjerkvig, Andreas Deutsch, Anja Voss-Böhme, Simone P. Niclou
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-16 (2019)
Cancer stem cells (CSCs) comprise a putative population that can drive growth and resistance. Here, in glioblastoma models the authors show that rather than being a distinct clonal entity, the CSC population represents a plastic state adoptable by mo
Externí odkaz:
https://doaj.org/article/f9953d80d7214efbbab8832d2c810d81
Autor:
Morgane Sanzey, Siti Aminah Abdul Rahim, Anais Oudin, Anne Dirkse, Tony Kaoma, Laurent Vallar, Christel Herold-Mende, Rolf Bjerkvig, Anna Golebiewska, Simone P Niclou
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0123544 (2015)
Major efforts have been put in anti-angiogenic treatment for glioblastoma (GBM), an aggressive and highly vascularized brain tumor with dismal prognosis. However clinical outcome with anti-angiogenic agents has been disappointing and tumors quickly d
Externí odkaz:
https://doaj.org/article/2ff02bf76eb6441fad18cfa6d4aeb05a
Autor:
Anna Golebiewska, Anne Dirkse, Thomas Buder, Yahaya A Yabo, Arnaud Muller, Petr V Nazarov, Rolf Bjerkvig, Alexander Skupin, Suresh K Poovathingal, Christel Herold-Mende, Anja Voss, Andreas Deutsch, Simone Niclou
Publikováno v:
Neuro Oncol
BACKGROUND Cellular heterogeneity is a hallmark of numerous cancer types, including Glioblastoma (GBM). Cancer stem cells (CSC) have been accounted for the generation of phenotypic heterogeneity and tumor progression in GBM. Recent data, however, sug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72912b41f6cde7a39322dc4ad3e9f202
https://europepmc.org/articles/PMC6847120/
https://europepmc.org/articles/PMC6847120/
Autor:
Simone P. Niclou, Suresh Poovathingal, Thomas Buder, Christel Herold-Mende, Rolf Bjerkvig, Arnaud Muller, Anna Golebiewska, Anja Voss-Böhme, Andreas Deutsch, Anne Dirkse, Yahaya A Yabo, Alexander Skupin, Petr V. Nazarov
Publikováno v:
Neuro Oncol
BACKGROUND Cellular heterogeneity has been well established within numerous cancer types, including malignant brain tumours. Initially, cancer stem cells (CSC) have been accounted for formation of phenotypic heterogeneity and tumor progression in gli
Autor:
Thomas Buder, Andreas Deutsch, Christel Herold-Mende, Simone P. Niclou, Rolf Bjerkvig, Anna Golebiewska, Arnaud Muller, Suresh Poovathingal, Anja Voss-Böhme, Anne Dirkse
Publikováno v:
ESMO Open. 3:A18
Introduction To date there is no curative treatment available for patients with Glioblastoma (GBM). The cancer stem cell (CSC) hypothesis posits that GBMs rely on a small subpopulation of cells with stemness properties responsible for tumour progress
Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma
Autor:
Simone P. Niclou, Tony Kaoma, Morgane Sanzey, Siti Aminah Abdul Rahim, Rolf Bjerkvig, Anne Dirkse, Christel Herold-Mende, Anais Oudin, Laurent Vallar, Anna Golebiewska
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0123544 (2015)
PLoS ONE
PLoS ONE
Major efforts have been put in anti-angiogenic treatment for glioblastoma (GBM), an aggressive and highly vascularized brain tumor with dismal prognosis. However clinical outcome with anti-angiogenic agents has been disappointing and tumors quickly d
Autor:
Stephen Senn, Nicolaas H. C. Brons, Simone P. Niclou, Anne Dirkse, Andreas Deutsch, Nicolas Sauvageot, Thomas Buder, Sonia Leite, Anna Golebiewska, Christel Herold-Mende
Publikováno v:
Neuro-Oncology. 18:vi185-vi185
Autor:
N. Sauvageot, Simone P. Niclou, S. Leite, Thomas Buder, N.H.C. Brons, Christel Herold-Mende, A. Golebiewska, S. Senn, Andreas Deutsch, Anne Dirkse
Publikováno v:
European Journal of Cancer. 61:S78
Publikováno v:
European Journal of Cancer. 50:S45